BMI1 and glioblastoma: On the other hand, miR‐194, miR‐429, and miR‐340 demonstrate tumor suppressive properties in GBM by targeting Bmi‐1 to suppress glioma cell migration, invasion, and epithelial‐to‐mesenchymal transition [77, 78, 79].